TISSUE REGENIX GROUP PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 62 GBX | 0.00% |
|
+0.81% | +19.23% |
| 03-19 | Tissue Regenix annual loss narrows sharply as revenue jumps | AN |
| 03-19 | Earnings Flash (TRX.L) TISSUE REGENIX GROUP Reports FY23 Revenue $29.5M | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Medical Software & Technology Services
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 55.49M | - | |||||
| 33.06B | ||||||
| 7.99B | ||||||
| 4.34B | ||||||
| 2.62B | ||||||
| 1.46B | - |
